REDBANK, NJ-Frost and Sullivan have awarded Ansell Healthcare, Inc., the 2000 Market Engineering Award for Product Line Strategy.
Ansell Healthcare is a manufacturer of barrier protective products. The company has been recognized for its ability to optimize their product line by leveraging products with various price, performance, and feature points.
Each year, Frost and Sullivan recognize an outstanding industry achievement by presenting marketing engineering awards to top companies in a variety of regional and global markets. The Market Engineering Award for Product Line Strategy is awarded to companies who demonstrate the most insight into customer need and demand. The criteria used to determine the recipient include: introduction of new products, strategically positioned to balance the product line; ability to accommodate different market segments, or different markets within an industry, finding different purposes for a technology; enhancement of product offerings through optimization of packaging, service, delivery, financing and/or other value-added services; and strategic technology or marketing acquisitions or alliances.
For more information visit www.ansell.com
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.